Surgical Hemostat, Internal Tissue Sealant and Adhesion Barrier Market: Global Industry Analysis and Forecast to 2020


  • To Be Published : Feb-2017 |
  • Status : Work in progress |
  • Format :

Surgical haemostatic agents and tissue sealant are used to stop bleeding during the surgery in the areas where cautery is difficult. Synthetic based tissue sealant and protein based tissue sealant are the type of sealants. Synthetic sealant helps in decreasing the risks of diseases and allergic reactions. Synthetic sealant don not contain any human or animal-derived products. Adhesion barrier are used to prevent fibrin formation bridges between the damaged tissues. Some of the types of adhesion barriers are film based, gel based and hydroflotation based adhesion barriers. 

North America dominates the global market for surgical hemostat, internal tissue sealant and adhesion barrier due to large number of aging population and increase in number of procedures using hemostat, sealant and adhesion barrier. Asia followed by the Europe are expected to show high growth rates in the next five years in global surgical hemostat, internal tissue sealant and adhesion barrier market. China and India are expected to be the fastest growing surgical hemostat, internal tissue sealant and adhesion barrier markets in Asia-Pacific region. Some of the key driving forces for surgical hemostat, internal tissue sealant and adhesion barrier market in emerging countries are large pool of patients, increased government funding and rising healthcare expenditure.

In recent times there is increased use of surgical hemostat, internal tissue sealant and adhesion barrier due to increasing number of surgical procedures. Rise in aging population and lower complication rates from the use of these products are some of the key factors driving the growth for global surgical hemostat, internal tissue sealant and adhesion barrier market. In addition, increasing healthcare awareness is also fuelling the growth of global surgical hemostat, internal tissue sealant and adhesion barrier market. However, complexity of procedure, economic slowdown and increasing adoption of minimal invasive surgery are some of the major factors restraining the growth for global surgical hemostat, internal tissue sealant and adhesion barrier market. 

High cost of surgical hemostat, internal tissue sealant and adhesion barrier could lead a challenge for the global surgical hemostat, internal tissue sealant and adhesion barrier market. Some of the major companies operating in the global surgical hemostat, internal tissue sealant and adhesion barrier market are Johnson & Johnson, Bartex International Inc., Takeda Pharmaceuticals International GmbH, B. Braun Melsungen AG., 3M Healthcare Ltd. and Lohmann & Rauscher GmbH & Co. KG.

Key points covered in the report

  • Report segments the market on the basis of types, application, products, technology, etc (as applicable)
  • The report covers geographic segmentation

    • North America
    • Europe
    • Asia
    • RoW
  • The report provides the market size and forecast for the different segments and geographies for the period of 2010 to 2020
  • The report provides company profiles of some of the leading companies operating in the market
  • The report also provides porters five forces analysis of the market.
Back To Top